Ferrer-Pérez EI, David-Pardo DG, Gómez-Medina AM, Muñoz-Velandia Óscar M, Parra-Prieto D, Kerguelen-Villadiego A, Salgado-Sánchez JC, Quijano-Naranjo JE, Jojoa-Jojoa RI, Gómez Giraldo CM, Henao-Carrillo DC. In-hospital hyperglycemia is more important than a history of diabetes in predicting the occurrence of adverse clinical outcomes in hospitalized patients with COVID-19. Rev.ACE [Internet]. 2023 Oct. 31 [cited 2024 Jul. 16];10(4). Available from: https://revistaendocrino.org/index.php/rcedm/article/view/811